Bioconjugation studies of an EGF-R targeting ligand on dendronized iron oxide nanoparticles to target head and neck cancer cells.
Freis B, Ramírez MLÁ, Furgiuele S, Journe F, Cheignon C, Charbonnière LJ, Henoumont C, Kiefer C, Mertz D, Affolter-Zbaraszczuk C, Meyer F, Saussez S, Laurent S, Tasso M, Bégin-Colin S.
Freis B, et al. Among authors: cheignon c.
Int J Pharm. 2023 Mar 25;635:122654. doi: 10.1016/j.ijpharm.2023.122654. Epub 2023 Jan 30.
Int J Pharm. 2023.
PMID: 36720449
Free article.